- Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy . . .
Theravance Biopharma, Inc ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that it has entered into a definitive agreement to sell its remaining royalty interest in net
- TBPH to Sell Remaining Trelegy Royalty Interest to GSK, Stock Rises
Theravance to sell its remaining Trelegy royalty interest to GSK for $225M, with shares jumping 22% on the deal's announcement
- Yahoo Finance - Stock Market Live, Quotes, Business Finance News
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life
- Theravance Biopharma, Inc. (TBPH) - Yahoo Finance
Get the latest Theravance Biopharma, Inc (TBPH) stock news and headlines to help you in your trading and investing decisions
- Trending tickers: IAG, Novo Nordisk, Shell, Stellantis, LVMH
Chaos in the Middle East was guiding markets on Monday, with airlines and oil on high alert
- Yahoo Finance
We would like to show you a description here but the site won’t allow us
- Theravance Biopharma, Inc. (TBPH) - Yahoo Finance
Find the latest Theravance Biopharma, Inc (TBPH) stock quote, history, news and other vital information to help you with your stock trading and investing
- Theravance Biopharma, Inc. (TBPH) - Yahoo Finance
Interactive Chart for Theravance Biopharma, Inc (TBPH), analyze all the data with a huge range of indicators
|